Sol-Gel Technologies (SLGL) Times Interest Earned (2017 - 2025)
Sol-Gel Technologies' (SLGL) quarterly Times Interest Earned came in at -$0.06 in Q4 2025, up 52.4% year-on-year from -$0.04 in Q4 2024, and up 52.4% on a QoQ basis from -$0.12 in Q4 2024.
Sol-Gel Technologies (SLGL) Times Interest Earned (2017 - 2025) Analysis & Trends
Sol-Gel Technologies (SLGL) has 9 years of Times Interest Earned data on file, last reported at -$0.06 in Q4 2025.
- On a quarterly basis, Times Interest Earned rose 52.4% year-over-year to -$0.06 in Q4 2025; TTM through Dec 2025 was $0.18, a 540.25% increase from a year earlier, with the FY2025 full-year figure at -$0.13, up 46.6% from the prior year.
- Times Interest Earned for Q4 2025 stood at -$0.06, up from -$0.12 in the prior quarter.
- Over the last five years, Times Interest Earned for SLGL reached as high as $34.21 in Q4 2021 and fell as low as -$0.14 in Q4 2022.
- Historically, Times Interest Earned has averaged $6.76 across 5 years, with a median of -$0.11 in 2023.
- Across the five-year window, Times Interest Earned soared 291.4% in 2021 and sank 100.41% in 2022, its largest moves.
- Year by year, Times Interest Earned stood at $34.21 in 2021, then plunged by 100.41% to -$0.14 in 2022, then climbed by 18.71% to -$0.11 in 2023, then fell by 8.54% to -$0.12 in 2024, then soared by 52.4% to -$0.06 in 2025.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$0.06 in Q4 2025, -$0.12 in Q4 2024, and -$0.11 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Sol-Gel Technologies | 227.58 Mn | 217.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.06 |
| Dec 31, 2024 | -0.12 |
| Dec 31, 2023 | -0.11 |
| Dec 31, 2022 | -0.14 |
| Dec 31, 2021 | 34.21 |
| Dec 31, 2020 | -17.87 |
| Dec 31, 2019 | -146.19 |
| Dec 31, 2018 | 46.31 |
| Dec 31, 2017 | 0.25 |